Cargando…
Approaches to interpret the outcomes of a network meta-analysis on comparative efficacy of different targeted therapies plus fulvestrant for advanced breast cancer following progression on prior endocrine therapy
Autores principales: | Jayaraj, Rama, Kumarasamy, Chellan, Sabarimurugan, Shanthi, Samiappan, Suja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489674/ https://www.ncbi.nlm.nih.gov/pubmed/31114370 http://dx.doi.org/10.2147/CMAR.S199442 |
Ejemplares similares
-
The Significance of miRNAs as a Prognostic Biomarker for Survival Outcome in T Cell – Acute Lymphoblastic Leukemia Patients: A Systematic Review and Meta-Analysis
por: Sabarimurugan, Shanthi, et al.
Publicado: (2020) -
Prognostic miRNA classifiers in t cell acute lymphoblastic leukemia: Study protocol for a systematic review and meta-analysis of observational clinical studies
por: Sabarimurugan, Shanthi, et al.
Publicado: (2019) -
Prognostic significance of blood inflammatory biomarkers NLR, PLR, and LMR in cancer—A protocol for systematic review and meta-analysis
por: Kumarasamy, Chellan, et al.
Publicado: (2019) -
Commentary: Blood-Derived microRNAs for Pancreatic Cancer Diagnosis: A Narrative Review and Meta-Analysis
por: Jayaraj, Rama, et al.
Publicado: (2019) -
Diagnostic and prognostic value of microRNAs for cancers- strategies and approaches to improve the clinical utility
por: Jayaraj, Rama, et al.
Publicado: (2019)